Advisornet Financial’s Karyopharm Therapeutics KPTI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-13
| Closed | -$166 | – | 2107 |
|
|
2024
Q3 | $166 | Hold |
13
| – | – | ﹤0.01% | 2123 |
|
|
2024
Q2 | $174 | Hold |
13
| – | – | ﹤0.01% | 2032 |
|
|
2024
Q1 | $302 | Sell |
13
-34
| -72% | -$790 | ﹤0.01% | 1929 |
|
|
2023
Q4 | $606 | Hold |
47
| – | – | ﹤0.01% | 2039 |
|
|
2023
Q3 | $938 | Hold |
47
| – | – | ﹤0.01% | 1809 |
|
|
2023
Q2 | $1.25K | Hold |
47
| – | – | ﹤0.01% | 1827 |
|
|
2023
Q1 | $2.72K | Hold |
47
| – | – | ﹤0.01% | 1622 |
|
|
2022
Q4 | $2.38K | Hold |
47
| – | – | ﹤0.01% | 1633 |
|
|
2022
Q3 | $4K | Hold |
47
| – | – | ﹤0.01% | 1536 |
|
|
2022
Q2 | $3K | Hold |
47
| – | – | ﹤0.01% | 1612 |
|
|
2022
Q1 | $5K | Hold |
47
| – | – | ﹤0.01% | 1606 |
|
|
2021
Q4 | $5K | Sell |
47
-6
| -11% | -$638 | ﹤0.01% | 1639 |
|
|
2021
Q3 | $5K | Hold |
53
| – | – | ﹤0.01% | 1605 |
|
|
2021
Q2 | $8K | Hold |
53
| – | – | ﹤0.01% | 1452 |
|
|
2021
Q1 | $8K | Buy |
53
+13
| +33% | +$1.96K | ﹤0.01% | 1404 |
|
|
2020
Q4 | $9K | Hold |
40
| – | – | ﹤0.01% | 1300 |
|
|
2020
Q3 | $9K | Hold |
40
| – | – | ﹤0.01% | 1284 |
|
|
2020
Q2 | $11K | Buy |
40
+7
| +21% | +$1.93K | ﹤0.01% | 1268 |
|
|
2020
Q1 | $10K | Buy |
+33
| New | +$10K | ﹤0.01% | 1256 |
|